ZAQS.ORG

Sunday, March 01, 2026 1:58 AM ET

CNBC - Health

How the 'K-shaped' economy is showing up at two big U.S. gyms

17 hours ago

A rapid-fire update on our 4th Industrial Revolution stocks and our other names

17 hours ago

We're adding a stock to our Bullpen that is resistant to recessions, AI disruption

1 day ago

Trump angering MAHA with glyphosate order gives Democrats an opening

1 day ago

Novartis, Genentech file suit alleging illegal importation of prescription drug

2 days ago

Healthy Returns: What's next for Novo Nordisk's next obesity drug CagriSema

2 days ago

Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%

4 days ago

Eli Lilly launches new form of Zepbound with a month of doses in one pen

4 days ago

Novo Nordisk down 15% after weight loss drug fails to match Eli Lilly's in trial

5 days ago

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

9 days ago

Kennedy defends Trump glyphosate order as MAHA erupts

9 days ago

FDA chief calls for reforms as U.S. loses ground to China in early drug trials

9 days ago

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

10 days ago

FDA chief Marty Makary says more drugs should be available over the counter

10 days ago

Danaher is tapping the M&A well yet again. But we might have had enough

11 days ago

French prosecutors investigate Nestle, Danone over contaminated baby formula

11 days ago

Novo Nordisk faces a defining year in the obesity drug market

12 days ago

How largest health-care education company in U.S. is tackling growing jobs gap

17 days ago

Novo CEO sees 15 million patient opportunity in Medicare obesity coverage

17 days ago

Moderna says FDA refuses to review its application for experimental flu shot

18 days ago

CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold

18 days ago

Florida law models what genetic disease testing could be

18 days ago

FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims

18 days ago

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections

19 days ago

Hims & Hers stops offering weight loss pill after threats of legal action

19 days ago

Healthy Returns: Pfizer execs chart out obesity drug strategy

21 days ago

White House launches direct-to-consumer drug site TrumpRx. Here's what to know

23 days ago

Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline

23 days ago

Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar

24 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

25 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook

25 days ago

Merck tops quarterly estimates, posts modest outlook as generic competition looms

25 days ago

Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch

25 days ago

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

29 days ago